Digiday Programmatic Marketing Summit:

Last chance to save, pass prices rise after October 20

SECURE YOUR SEAT

Mushroom boardroom: Why some execs are using psychedelics to get through the workday

work overload gif

This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.

After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.

Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.

More in Marketing

In graphic detail: How AI is going to shape influencer marketing next year

With AI transforming the industry, Digiday has charted how the tech is expected to impact influencer marketing over the next year.

Brands are betting on creators to make their next hit series

Brands are betting (again) on original content, but this time with creators at the helm in hopes to make it stick.

Giant Eagle continues its strategic shift away from convenience stores and toward pharmacies

Giant Eagle rolled out a new business strategy called “Because it Matters” that will define its future growth, with an emphasis on value, improved quality and service, and remodeled stores.